Ultragenyx Pharmaceutical(RARE) - 2022 Q4 - Earnings Call Transcript

Company Participants Conference Call Participants Operator Joshua Higa I'd like to remind everyone that during today's call, we will be making forward-looking statements. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. Please refer to the risk factors discussed in our latest SEC filings. Emil Kakkis In 2022, we generated more than $350 million of global revenue in our fifth year as a commercial company. This year, we expect revenue to be in the ...